97 related articles for article (PubMed ID: 23443779)
1. [CD99 regulates redifferentiation of classical Hodgkin's lymphoma cell line L428 towards B cells].
Zhou X; Huang X; Huang Z; Wang Z; Zhao T
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):235-8. PubMed ID: 23443779
[TBL] [Abstract][Full Text] [Related]
2. CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation.
Huang X; Zhou X; Wang Z; Li F; Liu F; Zhong L; Li X; Han X; Wu Z; Chen S; Zhao T
Int J Cancer; 2012 Aug; 131(4):E382-94. PubMed ID: 22020966
[TBL] [Abstract][Full Text] [Related]
3. SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.
Jian W; Zhong L; Wen J; Tang Y; Qiu B; Wu Z; Yan J; Zhou X; Zhao T
PLoS One; 2015; 10(5):e0127568. PubMed ID: 26000982
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Septin2 in Hodgkin lymphoma cell line L428 and its role in promoting H/RS cells' redifferentiation to B lymphocytes].
Sun QC; Zhong L; Qiu B; Zhao T; Zhou XH
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):134-139. PubMed ID: 28279038
[No Abstract] [Full Text] [Related]
5. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype.
Kim SH; Shin YK; Lee IS; Bae YM; Sohn HW; Suh YH; Ree HJ; Rowe M; Park SH
Blood; 2000 Jan; 95(1):294-300. PubMed ID: 10607715
[TBL] [Abstract][Full Text] [Related]
6. [Construction of mic2/CD99 gene vector and its transfection in Hodgkin lymphoma L428 cell line].
Huang ZP; He Y; Zhou XH; Han XQ; Wu ZQ; Zhang Y; Wen ZH; Zhao T
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2407-9. PubMed ID: 20034888
[TBL] [Abstract][Full Text] [Related]
7. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2).
Kim SH; Choi EY; Shin YK; Kim TJ; Chung DH; Chang SI; Kim NK; Park SH
Blood; 1998 Dec; 92(11):4287-95. PubMed ID: 9834235
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the immunoglobulin heavy chain variable region gene in CD99-deficient BJAB cell line.
Suh YH; Kim MK; Shin YK; Kim SH; Oh KI; Gil M; Kim MK; Choi YL; Jung KC; Lee KM; Lee IS; Park SH
Mol Cells; 2002 Apr; 13(2):237-44. PubMed ID: 12018845
[TBL] [Abstract][Full Text] [Related]
9. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
[TBL] [Abstract][Full Text] [Related]
10. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
11. LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells.
Lee IS; Shin YK; Chung DH; Park SH
Leuk Lymphoma; 2001 Aug; 42(4):587-94. PubMed ID: 11697486
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
Schmid C; Pan L; Diss T; Isaacson PG
Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin and sternberg-reed cell antigen(s) detected by an antiserum to a cell line (L428) derived from Hodgkin's disease.
Stein H; Gerdes J; Kirchner H; Schaadt M; Diehl V
Int J Cancer; 1981 Oct; 28(4):425-9. PubMed ID: 6946981
[TBL] [Abstract][Full Text] [Related]
14. Analysis of CCL5 expression in classical Hodgkin's lymphoma L428 cell line.
Liu F; Zhang Y; Wu ZQ; Zhao T
Mol Med Rep; 2011; 4(5):837-41. PubMed ID: 21701779
[TBL] [Abstract][Full Text] [Related]
15. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
Siebert JD; McClure SP; Banks PM; Gulley ML
Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
[TBL] [Abstract][Full Text] [Related]
19. [Proteomic analysis and verification of protein expression after upregulation of human CD99 in Hodgkin lymphoma cell line L428].
Lin XL; Sun QC; Lu Y; Han XQ; Zhao T; Zhou XH
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):490-496. PubMed ID: 31340622
[No Abstract] [Full Text] [Related]
20. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
